Biocryst Pharmaceuticals Inc (BCRX) Operating Expenses & History | Stock Alarm

Demo Sign up Log In

Biocryst Pharmaceuticals Inc · Operating Expenses

BCRX Operating Expenses

Latest reported$534.75Mperiod endingJun 30, 2026

BCRX Operating Expenses ($2.50M → $534.75M)

Annual operating expenses

High-resolution chart · PNG

BCRX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period ending	Operating Expenses (USD)
Dec 31, 2025	514,773,000
Dec 31, 2024	440,770,000
Dec 31, 2023	430,460,000
Dec 31, 2022	412,668,000
Dec 31, 2021	327,626,000
Dec 31, 2020	190,893,000
Dec 31, 2019	144,189,000
Dec 31, 2018	114,402,000
Dec 31, 2017	80,895,000
Dec 31, 2016	72,261,000
Dec 31, 2015	85,805,000
Dec 31, 2014	59,257,000
Dec 31, 2013	47,950,000
Dec 31, 2012	58,290,000
Dec 31, 2011	69,230,000
Dec 31, 2010	96,652,000
Dec 31, 2009	83,783,000
Dec 31, 2008	83,725,861
Dec 31, 2007	103,517,958
Dec 31, 2006	53,191,745
Dec 31, 2005	27,328,700
Dec 31, 2004	22,088,767
Dec 31, 2003	14,334,000
Dec 31, 2002	18,329,295
Dec 31, 2001	16,143,146
Dec 31, 2000	13,147,608
Dec 31, 1999	11,100,000
Dec 31, 1998	12,900,000
Dec 31, 1997	13,900,000
Dec 31, 1996	3,200,000
Dec 31, 1995	2,800,000
Dec 31, 1994	2,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.